ReposiTrak, Inc.
TRAK NYSE Services-Computer Processing & Data Preparation Financials FY2017βFY2026
What ReposiTrak, Inc. does
No business description yet.
- Legal name
- ReposiTrak, Inc.
- Fiscal year ends
- June 30, 2026
- Latest annual report
- 10-K Β· Sep 28, 2026
- Accession Β· CIK
- 0001437749-26-031392
0000050471
Revenue and margins
ReposiTrak, Inc. had $23.3M of revenue in fiscal 2026, up 3.0% on the year before.
Net income and earnings per share
From fiscal 2017 to 2026, diluted EPS grew 11.2% a year. Loss periods are shown in red.
Returns on capital
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Cash flow
Free cash flow was $8.2M in fiscal 2026, 35.2% of revenue. Cash from operations minus capital spending.
Dividends, buybacks and share count
ReposiTrak, Inc. returned $3.4M to shareholders in fiscal 2026, 42% of free cash flow. The diluted share count fell 0.8%.
Balance sheet
Cash, debt and the ratios that show how comfortably ReposiTrak, Inc. can carry it.
| Fiscal year end | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|
| Cash and short-term investments | $21.5M | $24.0M | $25.2M | $28.6M | $27.3M |
| Debt incl. finance leases | β | $0.4M | $0.2M | $0.5M | $0.3M |
| Net debt / EBITDA | β | β3.8x | β4.0x | β3.8x | β3.2x |
| Debt / equity | β | 0.0x | 0.0x | 0.0x | 0.0x |
| Interest coverage | 99.7x | 83.5x | 178.2x | 127.9x | 203.7x |
| Current ratio | 4.4x | 6.4x | 6.4x | 6.1x | 3.9x |
| Quick ratio | 4.4x | 6.4x | 6.4x | 6.1x | 3.9x |
| Total assets | $49.3M | $50.6M | $51.6M | $55.3M | $60.9M |
| Total liabilities | $6.4M | $4.7M | $4.7M | $5.8M | $8.6M |
| Shareholders' equity | $42.9M | $45.9M | $46.9M | $49.5M | $52.3M |
| Net debt (β = net cash) | β | β$23.6M | β$24.9M | β$28.1M | β$27.0M |
Insider trades
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. 'Plan' marks trades under a pre-arranged Rule 10b5-1 plan.
Bought, 12 months
$0.0M
0 insiders
Sold, 12 months
$0.0M
0 insiders
Of sales under plans
β
$0.0M
No open-market insider trades in the last 12 months.
Piotroski F-score
Nine pass/fail tests of profitability, funding and efficiency. 8β9 is strong, 0β2 weak.
| Test | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net income is positive | β | β | β | β | β | β | β | β | β | β |
| Cash from operations is positive | β | β | β | β | β | β | β | β | β | β |
| Return on assets rose | β | β | β | β | β | β | β | β | β | β |
| Cash from operations exceeds net income | β | β | β | β | β | β | β | β | β | β |
| Debt fell relative to assets | β | β | β | β | β | β | β | β | β | β |
| Current ratio rose | β | β | β | β | β | β | β | β | β | β |
| Share count didn't rise | β | β | β | β | β | β | β | β | β | β |
| Gross margin rose | β | β | β | β | β | β | β | β | β | β |
| Revenue rose relative to assets | β | β | β | β | β | β | β | β | β | β |
| F-score | β / 3 | 4 / 8 | 6 / 8 | 5 / 8 | 9 / 9 | 7 / 8 | 8 / 8 | 8 / 9 | 6 / 9 | 6 / 9 |
| Accruals ratio | 3.3% | 2.6% | β1.3% | β4.9% | β2.4% | β4.0% | β6.5% | β2.0% | β2.7% | β1.1% |
| Altman Z'' | 2.91 | 4.46 | 5.28 | 4.54 | 5.83 | 8.63 | 12.49 | 13.04 | 12.29 | 9.51 |
10 years of figures
US$ millions unless stated. Hover a ratio's name for its definition.
| Fiscal year | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||||
| Revenue | $18.9M | $22.0M | $21.2M | $20.0M | $21.0M | $18.0M | $19.1M | $20.5M | $22.6M | $23.3M |
| Net interest income | β$0.0M | β$0.0M | β | β | β | β | β | β | β | β |
| Gross profit | $13.6M | $15.4M | $15.3M | $13.0M | $14.1M | $14.9M | $15.8M | $17.0M | $18.9M | $20.0M |
| Operating income | $3.9M | $3.5M | $4.0M | $1.5M | $2.9M | $4.4M | $5.1M | $5.0M | $6.2M | $7.8M |
| Interest expense | β | $0.2M | $0.0M | $0.1M | $0.1M | $0.0M | $0.1M | $0.0M | $0.0M | $0.0M |
| Pretax income | $3.9M | $3.5M | $4.0M | $1.6M | $4.2M | $4.1M | $5.9M | $6.3M | $7.7M | $9.5M |
| Income tax | $0.1M | $0.1M | $0.1M | $0.0M | $0.1M | $0.1M | $0.3M | $0.4M | $0.7M | $2.0M |
| Net income | $3.8M | $3.4M | $3.9M | $1.6M | $4.1M | $4.0M | $5.6M | $6.0M | $7.0M | $7.6M |
| Net income to common | $3.0M | $2.8M | $3.3M | $1.0M | $3.5M | $3.4M | $5.0M | $5.4M | $6.6M | $7.4M |
| Diluted EPS | $0.15 | $0.14 | $0.16 | $0.05 | $0.18 | $0.18 | $0.27 | $0.29 | $0.35 | $0.39 |
| Diluted shares | 0.02B | 0.02B | 0.02B | 0.02B | 0.02B | 0.02B | 0.02B | 0.02B | 0.02B | 0.02B |
| Cash flow | ||||||||||
| Cash from operations | $2.3M | $2.2M | $4.6M | $4.2M | $5.4M | $6.1M | $8.9M | $7.0M | $8.4M | $8.2M |
| Capital expenditure | $2.0M | $0.2M | $1.4M | $0.7M | $0.1M | $0.1M | $0.1M | $0.1M | $0.0M | $0.0M |
| Free cash flow | $0.3M | $2.0M | $3.1M | $3.5M | $5.3M | $6.1M | $8.7M | $6.9M | $8.4M | $8.2M |
| Depreciation and amortization | $0.5M | $0.6M | $0.6M | $0.8M | $1.0M | $0.9M | $1.1M | $1.2M | $1.3M | $0.6M |
| Stock-based compensation | β | β | β | β | $0.3M | $0.4M | $0.4M | $0.4M | $0.4M | $0.4M |
| Share buybacks | β | $0.0M | $0.5M | $2.2M | $1.3M | $6.1M | $1.3M | $1.5M | $0.2M | $1.8M |
| Dividends paid | β | β | β | β | $0.6M | $0.6M | $1.4M | $1.7M | $1.7M | $1.6M |
| Dividends and buybacks | β | $0.0M | $0.5M | $2.2M | $1.9M | $6.7M | $2.7M | $3.2M | $1.9M | $3.4M |
| Balance sheet | ||||||||||
| Cash and short-term investments | $14.1M | $14.9M | $18.6M | $20.3M | $24.1M | $21.5M | $24.0M | $25.2M | $28.6M | $27.3M |
| Total debt | β | β | β | $0.5M | $0.0M | β | $0.4M | $0.2M | $0.5M | $0.3M |
| Current assets | $18.7M | $23.7M | $26.5M | $27.1M | $29.7M | $26.6M | $27.3M | $29.3M | $33.7M | $32.8M |
| Current liabilities | $8.2M | $8.0M | $8.8M | $8.9M | $9.3M | $6.1M | $4.2M | $4.5M | $5.5M | $8.5M |
| Property and equipment, net | $2.1M | $1.9M | $3.0M | $3.0M | $2.6M | $0.8M | $1.0M | $0.5M | $0.6M | $0.3M |
| Goodwill | $20.9M | $20.9M | $20.9M | $20.9M | $20.9M | $20.9M | $20.9M | $20.9M | $20.9M | $20.9M |
| Intangible assets | $1.1M | $0.9M | $0.8M | $0.7M | $0.5M | β | β | β | β | β |
| Total assets | $45.9M | $49.3M | $52.9M | $53.4M | $55.0M | $49.3M | $50.6M | $51.6M | $55.3M | $60.9M |
| Total liabilities | $10.2M | $9.6M | $9.7M | $10.8M | $9.9M | $6.4M | $4.7M | $4.7M | $5.8M | $8.6M |
| Shareholders' equity | $35.7M | $39.7M | $43.2M | $42.6M | $45.1M | $42.9M | $45.9M | $46.9M | $49.5M | $52.3M |
| Margins | ||||||||||
| Gross margin | 71.9% | 70.1% | 72.5% | 65.1% | 67.2% | 82.3% | 82.7% | 83.3% | 83.7% | 85.8% |
| Operating margin | 20.6% | 16.0% | 18.8% | 7.4% | 13.8% | 24.5% | 26.7% | 24.6% | 27.5% | 33.7% |
| EBITDA margin | 23.2% | 18.8% | 21.7% | 11.4% | 18.6% | 29.3% | 32.3% | 30.4% | 33.1% | 36.5% |
| Net margin | 19.9% | 15.5% | 18.4% | 8.0% | 19.6% | 22.2% | 29.3% | 29.1% | 30.9% | 32.5% |
| FCF margin | 1.6% | 9.0% | 14.8% | 17.7% | 25.0% | 33.5% | 45.7% | 33.7% | 37.2% | 35.2% |
| Net interest share of revenue | β0.1% | β0.0% | β | β | β | β | β | β | β | β |
| Returns | ||||||||||
| Return on capital | β | β | β | 6.3% | 13.5% | β | 21.6% | 21.6% | 26.5% | 24.6% |
| Return on capital employed | 10.3% | 8.5% | 9.0% | 3.3% | 6.3% | 10.2% | 11.0% | 10.7% | 12.5% | 15.0% |
| Return on equity | 10.6% | 9.0% | 9.4% | 3.7% | 9.4% | 9.1% | 12.6% | 12.9% | 14.5% | 14.9% |
| Return on assets | 8.2% | 7.2% | 7.6% | 3.0% | 7.6% | 7.7% | 11.2% | 11.7% | 13.1% | 13.0% |
| Return on tangible equity | 21.7% | 15.8% | 15.4% | 4.8% | 14.9% | 15.5% | 20.0% | 20.8% | 23.1% | 23.6% |
| Growth | ||||||||||
| Revenue growth | β | 16.4% | β3.9% | β5.3% | 4.8% | β14.1% | 5.8% | 7.1% | 10.5% | 3.0% |
| Net income growth | β | β9.8% | 14.5% | β59.2% | 158.4% | β2.8% | 39.6% | 6.6% | 17.1% | 8.5% |
| EPS growth | β | β6.7% | 14.3% | β68.8% | 260.0% | 0.0% | 50.0% | 7.4% | 20.7% | 11.4% |
| FCF growth | β | 559.2% | 58.5% | 13.2% | 48.2% | 15.2% | 44.2% | β21.0% | 22.0% | β2.3% |
| Share count change | β | 0.1% | 0.4% | β2.5% | β0.5% | β1.9% | β3.2% | 0.9% | 1.1% | β0.8% |
| Financial health | ||||||||||
| Net debt / EBITDA | β | β | β | β8.7x | β6.2x | β | β3.8x | β4.0x | β3.8x | β3.2x |
| Debt / equity | β | β | β | 0.0x | 0.0x | β | 0.0x | 0.0x | 0.0x | 0.0x |
| Interest coverage | β | 21.1x | 93.4x | 21.8x | 27.1x | 99.7x | 83.5x | 178.2x | 127.9x | 203.7x |
| Current ratio | 2.3x | 3.0x | 3.0x | 3.0x | 3.2x | 4.4x | 6.4x | 6.4x | 6.1x | 3.9x |
| Quick ratio | 2.3x | 3.0x | 3.0x | 3.0x | 3.2x | 4.4x | 6.4x | 6.4x | 6.1x | 3.9x |
| Capital allocation | ||||||||||
| Capex / revenue | 10.3% | 0.9% | 6.8% | 3.2% | 0.7% | 0.3% | 0.7% | 0.4% | 0.1% | 0.1% |
| Stock comp / revenue | β | β | β | β | 1.6% | 2.3% | 2.0% | 1.8% | 1.8% | 1.9% |
| Payouts / FCF | β | 0.0% | 15.4% | 60.9% | 36.1% | 111.3% | 31.2% | 47.0% | 22.1% | 41.8% |
| Quality scores | ||||||||||
| Piotroski F-score | β | 4.0 | 6.0 | 5.0 | 9.0 | 7.0 | 8.0 | 8.0 | 6.0 | 6.0 |
| Altman Z'' | 2.9 | 4.5 | 5.3 | 4.5 | 5.8 | 8.6 | 12.5 | 13.0 | 12.3 | 9.5 |
| Accruals ratio | 3.3% | 2.6% | β1.3% | β4.9% | β2.4% | β4.0% | β6.5% | β2.0% | β2.7% | β1.1% |
Source: SEC EDGAR XBRL filings (CIK 0000050471). Data updated October 24, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only β not investment advice. Check the original filings before relying on any figure.